-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On February 15, Shanghai issued a series of online purchase notices, including self-paid drugs and drugs limited to pharmacies, and closed some drug purchases at the same time
.
Among them, according to the requirements of the "Notice on the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet" and the "Notice on Further Improvement of the Matters Concerning the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet", the drugs applied for by medical institutions shall be issued within 180 days from the date of publication and implementation.
, the medical institution submitting the application needs to complete the negotiated purchase and confirm the acceptance, and the unfinished drugs will not be able to continue to purchase on the Sunshine platform
.
Since last year, 18 medicines in Shanghai have been closed for purchase because medical institutions have not completed the negotiation and acceptance
.
.
Among them, according to the requirements of the "Notice on the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet" and the "Notice on Further Improvement of the Matters Concerning the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet", the drugs applied for by medical institutions shall be issued within 180 days from the date of publication and implementation.
, the medical institution submitting the application needs to complete the negotiated purchase and confirm the acceptance, and the unfinished drugs will not be able to continue to purchase on the Sunshine platform
.
Since last year, 18 medicines in Shanghai have been closed for purchase because medical institutions have not completed the negotiation and acceptance
.
Periodic closure mechanism to clear off the drugs linked to the Internet
It is understood that the "full online negotiation" required by Shanghai is directly negotiated by medical institutions designated by medical insurance and drug manufacturers , and the inquiry and negotiation will be implemented in the form of "push information, green line reference, yellow line reminder, and red line interception"
.
.
On February 15, Shanghai issued a notice to close the procurement of 4 drugs
.
In early February last year, the Shanghai Pharmaceutical Office issued a notice to close the purchase of 13 drugs, involving Hengrui's cisatracurium besylate injection and Chia Tai Tianqing's docetaxel injection
.
In March last year, the purchase of Wuhan Nuoan's mometasone furoate cream was closed
.
.
In early February last year, the Shanghai Pharmaceutical Office issued a notice to close the purchase of 13 drugs, involving Hengrui's cisatracurium besylate injection and Chia Tai Tianqing's docetaxel injection
.
In March last year, the purchase of Wuhan Nuoan's mometasone furoate cream was closed
.
Shanghai closes drug information sheet (February 2022)
Shanghai Closes Drug Information Form (February 2021)
Shanghai closes drug information sheet (March 2021)
Cisatracurium besylate is a neuromuscular blocking agent
.
According to data from Minet.
com, in 2019, the sales of cisatracurium in public medical institutions in China were close to 2.
8 billion yuan.
In 2020, due to the impact of the epidemic, sales declined
.
From the perspective of corporate competition, Hengrui is currently leading the market, with a market share of 72% in 2020
.
Cisatracurium besylate injection has been selected for the fifth batch of national procurement, and finally won the bid by three domestic pharmaceutical companies, Hengrui, Nanjing Jianyou and Hangzhou Aoya
.
Docetaxel is a taxane drug, and the terminal market size of Chinese public medical institutions in 2020 will exceed 3.
5 billion yuan
.
In the fifth batch of national procurement, the 20mg docetaxel injection (the highest effective declared price is 860 yuan/piece), the products of Hengrui, Chia Tai Tianqing, Yangzijiang, Qilu, Huiyu, and Osaikang all dropped by 90%.
% or more
.
.
According to data from Minet.
com, in 2019, the sales of cisatracurium in public medical institutions in China were close to 2.
8 billion yuan.
In 2020, due to the impact of the epidemic, sales declined
.
From the perspective of corporate competition, Hengrui is currently leading the market, with a market share of 72% in 2020
.
Cisatracurium besylate injection has been selected for the fifth batch of national procurement, and finally won the bid by three domestic pharmaceutical companies, Hengrui, Nanjing Jianyou and Hangzhou Aoya
.
Docetaxel is a taxane drug, and the terminal market size of Chinese public medical institutions in 2020 will exceed 3.
5 billion yuan
.
In the fifth batch of national procurement, the 20mg docetaxel injection (the highest effective declared price is 860 yuan/piece), the products of Hengrui, Chia Tai Tianqing, Yangzijiang, Qilu, Huiyu, and Osaikang all dropped by 90%.
% or more
.
At the same time, Shanghai also regularly closes the purchase status of drugs that have not been purchased within a year, and selects them for invalidation treatment
.
At the end of April last year, Shanghai closed as many as 2,051 drugs without purchase records (medical insurance drugs), involving well-known companies such as AstraZeneca, BMS, Sanofi, Hansoh, and Kelun
.
In the same month, Shanghai shut down unrecorded medicines (self-paid medicines), including 740 medicines
.
.
At the end of April last year, Shanghai closed as many as 2,051 drugs without purchase records (medical insurance drugs), involving well-known companies such as AstraZeneca, BMS, Sanofi, Hansoh, and Kelun
.
In the same month, Shanghai shut down unrecorded medicines (self-paid medicines), including 740 medicines
.
Except for Shanghai, all provinces have established a network withdrawal mechanism, especially for large-scale processing of drugs without purchase records
.
On February 14, Jiangsu issued a notice that on March 1, the eligibility of 58 drugs to be listed on the Internet would be revoked
.
And all over the country have also suspended or revoked the online drugs that have quality problems, discontinued production, cancellation, and have not been sold for more than one year, ranging from dozens to more than 10,000
.
.
On February 14, Jiangsu issued a notice that on March 1, the eligibility of 58 drugs to be listed on the Internet would be revoked
.
And all over the country have also suspended or revoked the online drugs that have quality problems, discontinued production, cancellation, and have not been sold for more than one year, ranging from dozens to more than 10,000
.
From the perspective of the industry, no transaction record for half a year or more means that there will be no hospital purchasing for a long time, and related drugs will face greater market pressure
.
In the past two years, all localities have been sorting out online drugs that have no actual purchase behavior.
In the future, provinces will continue to speed up the implementation of this work, and more drugs will face withdrawal by then
.
.
In the past two years, all localities have been sorting out online drugs that have no actual purchase behavior.
In the future, provinces will continue to speed up the implementation of this work, and more drugs will face withdrawal by then
.
Restrict pharmacies to sell 19 drugs on the Internet
On the same day, Shanghai also announced the first batch of 2022 restrictions on online purchases of pharmacy drugs, with a total of 19 drugs listed
.
Drug information will be pushed to designated pharmacies, effective February 17, 2022
.
.
Drug information will be pushed to designated pharmacies, effective February 17, 2022
.
Shanghai 2022 First Batch of Drugs Restricted to Pharmacies Listed on the Internet
Drugstore-restricted drugs mainly refer to drugs that fall within the scope of the Shanghai Medical Insurance Catalogue and whose voluntary applications are limited to designated drugstores
.
It is understood that those who meet one of the following conditions can apply for listing on the Internet: the company has already listed drugs of the same variety in designated medical institutions for price negotiation; drugs with the same generic name and specifications have been listed in designated medical institutions for price negotiations; confirmation only For drugs sold in designated pharmacies (for the same variety in designated medical institutions in this city without companies listing on the Internet to negotiate prices), a chain of designated pharmacies or three single designated pharmacies shall submit purchase applications
.
.
It is understood that those who meet one of the following conditions can apply for listing on the Internet: the company has already listed drugs of the same variety in designated medical institutions for price negotiation; drugs with the same generic name and specifications have been listed in designated medical institutions for price negotiations; confirmation only For drugs sold in designated pharmacies (for the same variety in designated medical institutions in this city without companies listing on the Internet to negotiate prices), a chain of designated pharmacies or three single designated pharmacies shall submit purchase applications
.
It is worth noting that the medicines sold by designated pharmacies that belong to the "Shanghai Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog" must upload retail price information
.
The Shanghai Pharmacy Office pushes the basic information of medicines to the designated pharmacies through the Sunshine platform.
Combined with the relevant stipulations in the medical insurance service agreement of the designated pharmacies, the designated medical institutions purchase information such as the price of the same product of the same product or the same generic name, etc.
, to establish a price "red and yellow".
"Line" monitoring and early warning mechanism
.
.
The Shanghai Pharmacy Office pushes the basic information of medicines to the designated pharmacies through the Sunshine platform.
Combined with the relevant stipulations in the medical insurance service agreement of the designated pharmacies, the designated medical institutions purchase information such as the price of the same product of the same product or the same generic name, etc.
, to establish a price "red and yellow".
"Line" monitoring and early warning mechanism
.
The yellow line includes: the last uploaded price; the retail price of the drug with the same generic name (except for the original research drug or reference preparation) at the designated medical institution’s highest purchase price converted by the price difference
.
The red line includes: the retail price of the highest purchase price of the designated medical institution of the drug converted by the price difference rate; the retail price of the highest purchase price of the designated medical institution of the same type of drug of the company (excluding the original research drug or reference preparation) converted by the price difference rate
.
If the price is higher than the yellow line, the system will automatically remind, and if the price is higher than the red line, the system will automatically block
.
.
The red line includes: the retail price of the highest purchase price of the designated medical institution of the drug converted by the price difference rate; the retail price of the highest purchase price of the designated medical institution of the same type of drug of the company (excluding the original research drug or reference preparation) converted by the price difference rate
.
If the price is higher than the yellow line, the system will automatically remind, and if the price is higher than the red line, the system will automatically block
.
In addition, the Shanghai Pharmacy Office will regularly close the procurement status of drugs that have not uploaded retail prices within one year, and deal with the invalidation of the medical
institution .
Drugs whose retail prices have not been uploaded within two years and whose medical institutions have no medical insurance settlement will be treated as invalid basic information
.
institution .
Drugs whose retail prices have not been uploaded within two years and whose medical institutions have no medical insurance settlement will be treated as invalid basic information
.
It cannot be ignored that, as some regions incorporate retail pharmacies into centralized procurement, drug price supervision also covers pharmacies
.
.
In December last year, the Henan Provincial Medical Insurance Bureau decided to take some of the qualified medical insurance designated retail chain pharmacies as a pilot project and include them in the scope of centralized drug procurement in Henan Province
.
After the pilot is successful, all designated retail pharmacies for medical insurance in Henan will gradually be included in the scope of centralized drug procurement
.
It is understood that there are 83 varieties of the first batch of centralized medicines sold in these pharmacies, including anticancer drugs
.
In the future, as more and more regions incorporate pharmacies into centralized procurement, the price difference between in-hospital and out-of-hospital drug prices will rapidly narrow
.
.
After the pilot is successful, all designated retail pharmacies for medical insurance in Henan will gradually be included in the scope of centralized drug procurement
.
It is understood that there are 83 varieties of the first batch of centralized medicines sold in these pharmacies, including anticancer drugs
.
In the future, as more and more regions incorporate pharmacies into centralized procurement, the price difference between in-hospital and out-of-hospital drug prices will rapidly narrow
.
On February 15, Shanghai issued a series of online purchase notices, including self-paid drugs and drugs limited to pharmacies, and closed some drug purchases at the same time
.
Among them, according to the requirements of the "Notice on the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet" and the "Notice on Further Improvement of the Matters Concerning the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet", the drugs applied for by medical institutions shall be issued within 180 days from the date of publication and implementation.
, the medical institution submitting the application needs to complete the negotiated purchase and confirm the acceptance, and the unfinished drugs will not be able to continue to purchase on the Sunshine platform
.
Since last year, 18 medicines in Shanghai have been closed for purchase because medical institutions have not completed the negotiation and acceptance
.
.
Among them, according to the requirements of the "Notice on the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet" and the "Notice on Further Improvement of the Matters Concerning the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet", the drugs applied for by medical institutions shall be issued within 180 days from the date of publication and implementation.
, the medical institution submitting the application needs to complete the negotiated purchase and confirm the acceptance, and the unfinished drugs will not be able to continue to purchase on the Sunshine platform
.
Since last year, 18 medicines in Shanghai have been closed for purchase because medical institutions have not completed the negotiation and acceptance
.
Periodic closure mechanism to clear off the drugs linked to the Internet
It is understood that the "full online negotiation" required by Shanghai is directly negotiated by medical institutions designated by medical insurance and drug manufacturers , and the inquiry and negotiation will be implemented in the form of "push information, green line reference, yellow line reminder, and red line interception"
.
.
On February 15, Shanghai issued a notice to close the procurement of 4 drugs
.
In early February last year, the Shanghai Pharmaceutical Office issued a notice to close the purchase of 13 drugs, involving Hengrui's cisatracurium besylate injection and Chia Tai Tianqing's docetaxel injection
.
In March last year, the purchase of Wuhan Nuoan's mometasone furoate cream was closed
.
.
In early February last year, the Shanghai Pharmaceutical Office issued a notice to close the purchase of 13 drugs, involving Hengrui's cisatracurium besylate injection and Chia Tai Tianqing's docetaxel injection
.
In March last year, the purchase of Wuhan Nuoan's mometasone furoate cream was closed
.
Shanghai closes drug information sheet (February 2022)
Shanghai Closes Drug Information Form (February 2021)
Shanghai closes drug information sheet (March 2021)
Cisatracurium besylate is a neuromuscular blocking agent
.
According to data from Minet.
com, in 2019, the sales of cisatracurium in public medical institutions in China were close to 2.
8 billion yuan.
In 2020, due to the impact of the epidemic, sales declined
.
From the perspective of corporate competition, Hengrui is currently leading the market, with a market share of 72% in 2020
.
Cisatracurium besylate injection has been selected for the fifth batch of national procurement, and finally won the bid by three domestic pharmaceutical companies, Hengrui, Nanjing Jianyou and Hangzhou Aoya
.
Docetaxel is a taxane drug, and the terminal market size of Chinese public medical institutions in 2020 will exceed 3.
5 billion yuan
.
In the fifth batch of national procurement, the 20mg docetaxel injection (the highest effective declared price is 860 yuan/piece), the products of Hengrui, Chia Tai Tianqing, Yangzijiang, Qilu, Huiyu, and Osaikang all dropped by 90%.
% or more
.
.
According to data from Minet.
com, in 2019, the sales of cisatracurium in public medical institutions in China were close to 2.
8 billion yuan.
In 2020, due to the impact of the epidemic, sales declined
.
From the perspective of corporate competition, Hengrui is currently leading the market, with a market share of 72% in 2020
.
Cisatracurium besylate injection has been selected for the fifth batch of national procurement, and finally won the bid by three domestic pharmaceutical companies, Hengrui, Nanjing Jianyou and Hangzhou Aoya
.
Docetaxel is a taxane drug, and the terminal market size of Chinese public medical institutions in 2020 will exceed 3.
5 billion yuan
.
In the fifth batch of national procurement, the 20mg docetaxel injection (the highest effective declared price is 860 yuan/piece), the products of Hengrui, Chia Tai Tianqing, Yangzijiang, Qilu, Huiyu, and Osaikang all dropped by 90%.
% or more
.
At the same time, Shanghai also regularly closes the purchase status of drugs that have not been purchased within a year, and selects them for invalidation treatment
.
At the end of April last year, Shanghai closed as many as 2,051 drugs without purchase records (medical insurance drugs), involving well-known companies such as AstraZeneca, BMS, Sanofi, Hansoh, and Kelun
.
In the same month, Shanghai shut down unrecorded medicines (self-paid medicines), including 740 medicines
.
.
At the end of April last year, Shanghai closed as many as 2,051 drugs without purchase records (medical insurance drugs), involving well-known companies such as AstraZeneca, BMS, Sanofi, Hansoh, and Kelun
.
In the same month, Shanghai shut down unrecorded medicines (self-paid medicines), including 740 medicines
.
Except for Shanghai, all provinces have established a network withdrawal mechanism, especially for large-scale processing of drugs without purchase records
.
On February 14, Jiangsu issued a notice that on March 1, the eligibility of 58 drugs to be listed on the Internet would be revoked
.
And all over the country have also suspended or revoked the online drugs that have quality problems, discontinued production, cancellation, and have not been sold for more than one year, ranging from dozens to more than 10,000
.
.
On February 14, Jiangsu issued a notice that on March 1, the eligibility of 58 drugs to be listed on the Internet would be revoked
.
And all over the country have also suspended or revoked the online drugs that have quality problems, discontinued production, cancellation, and have not been sold for more than one year, ranging from dozens to more than 10,000
.
From the perspective of the industry, no transaction record for half a year or more means that there will be no hospital purchasing for a long time, and related drugs will face greater market pressure
.
In the past two years, all localities have been sorting out online drugs that have no actual purchase behavior.
In the future, provinces will continue to speed up the implementation of this work, and more drugs will face withdrawal by then
.
.
In the past two years, all localities have been sorting out online drugs that have no actual purchase behavior.
In the future, provinces will continue to speed up the implementation of this work, and more drugs will face withdrawal by then
.
Restrict pharmacies to sell 19 drugs on the Internet
On the same day, Shanghai also announced the first batch of 2022 restrictions on online purchases of pharmacy drugs, with a total of 19 drugs listed
.
Drug information will be pushed to designated pharmacies, effective February 17, 2022
.
.
Drug information will be pushed to designated pharmacies, effective February 17, 2022
.
Shanghai 2022 First Batch of Drugs Restricted to Pharmacies Listed on the Internet
Drugstore-restricted drugs mainly refer to drugs that fall within the scope of the Shanghai Medical Insurance Catalogue and whose voluntary applications are limited to designated drugstores
.
It is understood that those who meet one of the following conditions can apply for listing on the Internet: the company has already listed drugs of the same variety in designated medical institutions for price negotiation; drugs with the same generic name and specifications have been listed in designated medical institutions for price negotiations; confirmation only For drugs sold in designated pharmacies (for the same variety in designated medical institutions in this city without companies listing on the Internet to negotiate prices), a chain of designated pharmacies or three single designated pharmacies shall submit purchase applications
.
.
It is understood that those who meet one of the following conditions can apply for listing on the Internet: the company has already listed drugs of the same variety in designated medical institutions for price negotiation; drugs with the same generic name and specifications have been listed in designated medical institutions for price negotiations; confirmation only For drugs sold in designated pharmacies (for the same variety in designated medical institutions in this city without companies listing on the Internet to negotiate prices), a chain of designated pharmacies or three single designated pharmacies shall submit purchase applications
.
It is worth noting that the medicines sold by designated pharmacies that belong to the "Shanghai Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog" must upload retail price information
.
The Shanghai Pharmacy Office pushes the basic information of medicines to the designated pharmacies through the Sunshine platform.
Combined with the relevant stipulations in the medical insurance service agreement of the designated pharmacies, the designated medical institutions purchase information such as the price of the same product of the same product or the same generic name, etc.
, to establish a price "red and yellow".
"Line" monitoring and early warning mechanism
.
.
The Shanghai Pharmacy Office pushes the basic information of medicines to the designated pharmacies through the Sunshine platform.
Combined with the relevant stipulations in the medical insurance service agreement of the designated pharmacies, the designated medical institutions purchase information such as the price of the same product of the same product or the same generic name, etc.
, to establish a price "red and yellow".
"Line" monitoring and early warning mechanism
.
The yellow line includes: the last uploaded price; the retail price of the drug with the same generic name (except for the original research drug or reference preparation) at the designated medical institution’s highest purchase price converted by the price difference
.
The red line includes: the retail price of the highest purchase price of the designated medical institution of the drug converted by the price difference rate; the retail price of the highest purchase price of the designated medical institution of the same type of drug of the company (excluding the original research drug or reference preparation) converted by the price difference rate
.
If the price is higher than the yellow line, the system will automatically remind, and if the price is higher than the red line, the system will automatically block
.
.
The red line includes: the retail price of the highest purchase price of the designated medical institution of the drug converted by the price difference rate; the retail price of the highest purchase price of the designated medical institution of the same type of drug of the company (excluding the original research drug or reference preparation) converted by the price difference rate
.
If the price is higher than the yellow line, the system will automatically remind, and if the price is higher than the red line, the system will automatically block
.
In addition, the Shanghai Pharmacy Office will regularly close the procurement status of drugs that have not uploaded retail prices within one year, and deal with the invalidation of the medical
institution .
Drugs whose retail prices have not been uploaded within two years and whose medical institutions have no medical insurance settlement will be treated as invalid basic information
.
institution .
Drugs whose retail prices have not been uploaded within two years and whose medical institutions have no medical insurance settlement will be treated as invalid basic information
.
It cannot be ignored that, as some regions incorporate retail pharmacies into centralized procurement, drug price supervision also covers pharmacies
.
.
In December last year, the Henan Provincial Medical Insurance Bureau decided to take some of the qualified medical insurance designated retail chain pharmacies as a pilot project and include them in the scope of centralized drug procurement in Henan Province
.
After the pilot is successful, all designated retail pharmacies for medical insurance in Henan will gradually be included in the scope of centralized drug procurement
.
It is understood that there are 83 varieties of the first batch of centralized medicines sold in these pharmacies, including anticancer drugs
.
In the future, as more and more regions incorporate pharmacies into centralized procurement, the price difference between in-hospital and out-of-hospital drug prices will rapidly narrow
.
.
After the pilot is successful, all designated retail pharmacies for medical insurance in Henan will gradually be included in the scope of centralized drug procurement
.
It is understood that there are 83 varieties of the first batch of centralized medicines sold in these pharmacies, including anticancer drugs
.
In the future, as more and more regions incorporate pharmacies into centralized procurement, the price difference between in-hospital and out-of-hospital drug prices will rapidly narrow
.
On February 15, Shanghai issued a series of online purchase notices, including self-paid drugs and drugs limited to pharmacies, and closed some drug purchases at the same time
.
Among them, according to the requirements of the "Notice on the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet" and the "Notice on Further Improvement of the Matters Concerning the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet", the drugs applied for by medical institutions shall be issued within 180 days from the date of publication and implementation.
, the medical institution submitting the application needs to complete the negotiated purchase and confirm the acceptance, and the unfinished drugs will not be able to continue to purchase on the Sunshine platform
.
Since last year, 18 medicines in Shanghai have been closed for purchase because medical institutions have not completed the negotiation and acceptance
.
.
Among them, according to the requirements of the "Notice on the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet" and the "Notice on Further Improvement of the Matters Concerning the Full Implementation of the Public Negotiated Procurement of Drugs on the Internet", the drugs applied for by medical institutions shall be issued within 180 days from the date of publication and implementation.
, the medical institution submitting the application needs to complete the negotiated purchase and confirm the acceptance, and the unfinished drugs will not be able to continue to purchase on the Sunshine platform
.
Since last year, 18 medicines in Shanghai have been closed for purchase because medical institutions have not completed the negotiation and acceptance
.
Periodic closure mechanism to clear off the drugs linked to the Internet
Periodic closure mechanism to clear off the drugs linked to the Internet It is understood that the "full online negotiation" required by Shanghai is directly negotiated by medical institutions designated by medical insurance and drug manufacturers , and the inquiry and negotiation will be implemented in the form of "push information, green line reference, yellow line reminder, and red line interception"
.
enterprise enterprise enterprise.
On February 15, Shanghai issued a notice to close the procurement of 4 drugs
.
In early February last year, the Shanghai Pharmaceutical Office issued a notice to close the purchase of 13 drugs, involving Hengrui's cisatracurium besylate injection and Chia Tai Tianqing's docetaxel injection
.
In March last year, the purchase of Wuhan Nuoan's mometasone furoate cream was closed
.
.
In early February last year, the Shanghai Pharmaceutical Office issued a notice to close the purchase of 13 drugs, involving Hengrui's cisatracurium besylate injection and Chia Tai Tianqing's docetaxel injection
.
In March last year, the purchase of Wuhan Nuoan's mometasone furoate cream was closed
.
Shanghai closes drug information sheet (February 2022)
Shanghai Closes Drug Information Form (February 2021)
Shanghai closes drug information sheet (March 2021)
Cisatracurium besylate is a neuromuscular blocking agent
.
According to data from Minet.
com, in 2019, the sales of cisatracurium in public medical institutions in China were close to 2.
8 billion yuan.
In 2020, due to the impact of the epidemic, sales declined
.
From the perspective of corporate competition, Hengrui is currently leading the market, with a market share of 72% in 2020
.
Cisatracurium besylate injection has been selected for the fifth batch of national procurement, and finally won the bid by three domestic pharmaceutical companies, Hengrui, Nanjing Jianyou and Hangzhou Aoya
.
Docetaxel is a taxane drug, and the terminal market size of Chinese public medical institutions in 2020 will exceed 3.
5 billion yuan
.
In the fifth batch of national procurement, the 20mg docetaxel injection (the highest effective declared price is 860 yuan/piece), the products of Hengrui, Chia Tai Tianqing, Yangzijiang, Qilu, Huiyu, and Osaikang all dropped by 90%.
% or more
.
.
According to data from Minet.
com, in 2019, the sales of cisatracurium in public medical institutions in China were close to 2.
8 billion yuan.
In 2020, due to the impact of the epidemic, sales declined
.
From the perspective of corporate competition, Hengrui is currently leading the market, with a market share of 72% in 2020
.
Cisatracurium besylate injection has been selected for the fifth batch of national procurement, and finally won the bid by three domestic pharmaceutical companies, Hengrui, Nanjing Jianyou and Hangzhou Aoya
.
Docetaxel is a taxane drug, and the terminal market size of Chinese public medical institutions in 2020 will exceed 3.
5 billion yuan
.
In the fifth batch of national procurement, the 20mg docetaxel injection (the highest effective declared price is 860 yuan/piece), the products of Hengrui, Chia Tai Tianqing, Yangzijiang, Qilu, Huiyu, and Osaikang all dropped by 90%.
% or more
.
At the same time, Shanghai also regularly closes the purchase status of drugs that have not been purchased within a year, and selects them for invalidation treatment
.
At the end of April last year, Shanghai closed as many as 2,051 drugs without purchase records (medical insurance drugs), involving well-known companies such as AstraZeneca, BMS, Sanofi, Hansoh, and Kelun
.
In the same month, Shanghai shut down unrecorded medicines (self-paid medicines), including 740 medicines
.
.
At the end of April last year, Shanghai closed as many as 2,051 drugs without purchase records (medical insurance drugs), involving well-known companies such as AstraZeneca, BMS, Sanofi, Hansoh, and Kelun
.
In the same month, Shanghai shut down unrecorded medicines (self-paid medicines), including 740 medicines
.
Except for Shanghai, all provinces have established a network withdrawal mechanism, especially for large-scale processing of drugs without purchase records
.
On February 14, Jiangsu issued a notice that on March 1, the eligibility of 58 drugs to be listed on the Internet would be revoked
.
And all over the country have also suspended or revoked the online drugs that have quality problems, discontinued production, cancellation, and have not been sold for more than one year, ranging from dozens to more than 10,000
.
.
On February 14, Jiangsu issued a notice that on March 1, the eligibility of 58 drugs to be listed on the Internet would be revoked
.
And all over the country have also suspended or revoked the online drugs that have quality problems, discontinued production, cancellation, and have not been sold for more than one year, ranging from dozens to more than 10,000
.
From the perspective of the industry, no transaction record for half a year or more means that there will be no hospital purchasing for a long time, and related drugs will face greater market pressure
.
In the past two years, all localities have been sorting out online drugs that have no actual purchase behavior.
In the future, provinces will continue to speed up the implementation of this work, and more drugs will face withdrawal by then
.
hospital hospital hospital.
In the past two years, all localities have been sorting out online drugs that have no actual purchase behavior.
In the future, provinces will continue to speed up the implementation of this work, and more drugs will face withdrawal by then
.
Restrict pharmacies to sell 19 drugs on the Internet
Pharmacies are limited to pharmacies , pharmacies are restricted from selling 19 drugs on the Internet On the same day, Shanghai also announced the first batch of 2022 restrictions on online purchases of pharmacy drugs, with a total of 19 drugs listed
.
Drug information will be pushed to designated pharmacies, effective February 17, 2022
.
.
Drug information will be pushed to designated pharmacies, effective February 17, 2022
.
Shanghai 2022 First Batch of Drugs Restricted to Pharmacies Listed on the Internet
Drugstore-restricted drugs mainly refer to drugs that fall within the scope of the Shanghai Medical Insurance Catalogue and whose voluntary applications are limited to designated drugstores
.
It is understood that those who meet one of the following conditions can apply for listing on the Internet: the company has already listed drugs of the same variety in designated medical institutions for price negotiation; drugs with the same generic name and specifications have been listed in designated medical institutions for price negotiations; confirmation only For drugs sold in designated pharmacies (for the same variety in designated medical institutions in this city without companies listing on the Internet to negotiate prices), a chain of designated pharmacies or three single designated pharmacies shall submit purchase applications
.
.
It is understood that those who meet one of the following conditions can apply for listing on the Internet: the company has already listed drugs of the same variety in designated medical institutions for price negotiation; drugs with the same generic name and specifications have been listed in designated medical institutions for price negotiations; confirmation only For drugs sold in designated pharmacies (for the same variety in designated medical institutions in this city without companies listing on the Internet to negotiate prices), a chain of designated pharmacies or three single designated pharmacies shall submit purchase applications
.
It is worth noting that the medicines sold by designated pharmacies that belong to the "Shanghai Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog" must upload retail price information
.
The Shanghai Pharmacy Office pushes the basic information of medicines to the designated pharmacies through the Sunshine platform.
Combined with the relevant stipulations in the medical insurance service agreement of the designated pharmacies, the designated medical institutions purchase information such as the price of the same product of the same product or the same generic name, etc.
, to establish a price "red and yellow".
"Line" monitoring and early warning mechanism
.
.
The Shanghai Pharmacy Office pushes the basic information of medicines to the designated pharmacies through the Sunshine platform.
Combined with the relevant stipulations in the medical insurance service agreement of the designated pharmacies, the designated medical institutions purchase information such as the price of the same product of the same product or the same generic name, etc.
, to establish a price "red and yellow".
"Line" monitoring and early warning mechanism
.
The yellow line includes: the last uploaded price; the retail price of the drug with the same generic name (except for the original research drug or reference preparation) at the designated medical institution’s highest purchase price converted by the price difference
.
The red line includes: the retail price of the highest purchase price of the designated medical institution of the drug converted by the price difference rate; the retail price of the highest purchase price of the designated medical institution of the same type of drug of the company (excluding the original research drug or reference preparation) converted by the price difference rate
.
If the price is higher than the yellow line, the system will automatically remind, and if the price is higher than the red line, the system will automatically block
.
medicines medicines medicines.
The red line includes: the retail price of the highest purchase price of the designated medical institution of the drug converted by the price difference rate; the retail price of the highest purchase price of the designated medical institution of the same type of drug of the company (excluding the original research drug or reference preparation) converted by the price difference rate
.
If the price is higher than the yellow line, the system will automatically remind, and if the price is higher than the red line, the system will automatically block
.
In addition, the Shanghai Pharmacy Office will regularly close the procurement status of drugs that have not uploaded retail prices within one year, and deal with the invalidation of the medical
institution .
Drugs whose retail prices have not been uploaded within two years and whose medical institutions have no medical insurance settlement will be treated as invalid basic information
.
medicine medicine medicineinstitution .
Drugs whose retail prices have not been uploaded within two years and whose medical institutions have no medical insurance settlement will be treated as invalid basic information
.
It cannot be ignored that, as some regions incorporate retail pharmacies into centralized procurement, drug price supervision also covers pharmacies
.
.
In December last year, the Henan Provincial Medical Insurance Bureau decided to take some of the qualified medical insurance designated retail chain pharmacies as a pilot project and include them in the scope of centralized drug procurement in Henan Province
.
After the pilot is successful, all designated retail pharmacies for medical insurance in Henan will gradually be included in the scope of centralized drug procurement
.
It is understood that there are 83 varieties of the first batch of centralized medicines sold in these pharmacies, including anticancer drugs
.
In the future, as more and more regions incorporate pharmacies into centralized procurement, the price difference between in-hospital and out-of-hospital drug prices will rapidly narrow
.
.
After the pilot is successful, all designated retail pharmacies for medical insurance in Henan will gradually be included in the scope of centralized drug procurement
.
It is understood that there are 83 varieties of the first batch of centralized medicines sold in these pharmacies, including anticancer drugs
.
In the future, as more and more regions incorporate pharmacies into centralized procurement, the price difference between in-hospital and out-of-hospital drug prices will rapidly narrow
.
